Stericycle (NASDAQ:SRCL) Rating Lowered to Hold at

Stericycle (NASDAQ:SRCLGet Rating) was downgraded by from a “buy” rating to a “hold” rating in a report released on Thursday.

Other equities analysts have also issued research reports about the company. Zacks Investment Research lowered Stericycle from a “hold” rating to a “sell” rating and set a $62.00 price target on the stock. in a research note on Tuesday, March 1st. Robert W. Baird decreased their price target on Stericycle from $77.00 to $72.00 and set an “outperform” rating on the stock in a research note on Friday, February 25th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $67.00.

Shares of NASDAQ SRCL opened at $53.41 on Thursday. The stock has a market capitalization of $4.92 billion, a PE ratio of -172.28, a P/E/G ratio of 3.16 and a beta of 1.30. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.79 and a quick ratio of 0.79. The business has a fifty day moving average price of $57.21 and a two-hundred day moving average price of $59.78. Stericycle has a fifty-two week low of $53.25 and a fifty-two week high of $79.97.

Stericycle (NASDAQ:SRCLGet Rating) last issued its quarterly earnings results on Thursday, February 24th. The business services provider reported $0.38 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.44 by ($0.06). Stericycle had a negative net margin of 1.05% and a positive return on equity of 8.26%. The business had revenue of $657.30 million during the quarter, compared to the consensus estimate of $662.25 million. During the same quarter in the previous year, the business posted $0.59 EPS. The company’s revenue for the quarter was up .2% on a year-over-year basis. On average, equities analysts expect that Stericycle will post 2.19 EPS for the current year.

A number of hedge funds have recently modified their holdings of SRCL. Black Creek Investment Management Inc. bought a new stake in Stericycle during the 3rd quarter worth $119,149,000. Capital Research Global Investors grew its position in Stericycle by 24.0% during the 4th quarter. Capital Research Global Investors now owns 4,345,073 shares of the business services provider’s stock worth $259,140,000 after acquiring an additional 840,222 shares during the last quarter. Norges Bank acquired a new position in Stericycle during the 4th quarter worth about $46,372,000. Impax Asset Management Group plc lifted its holdings in Stericycle by 36.3% during the 4th quarter. Impax Asset Management Group plc now owns 2,211,634 shares of the business services provider’s stock worth $130,961,000 after buying an additional 589,128 shares during the period. Finally, Mondrian Investment Partners LTD lifted its holdings in Stericycle by 19.2% during the 4th quarter. Mondrian Investment Partners LTD now owns 2,150,877 shares of the business services provider’s stock worth $128,278,000 after buying an additional 347,066 shares during the period. Institutional investors and hedge funds own 97.67% of the company’s stock.

About Stericycle (Get Rating)

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.

Featured Stories

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with's FREE daily email newsletter.